Brains of 42 COVID-19 decedents and 107 non-COVID-19 controls were studied. RT-PCR
screening of 16 regions from 20 COVID-19 autopsies found SARS-CoV-2 E gene viral …

The type I interferon (IFN) response is the body's typical immune defense against viruses.
Previous studies linked high expression of genes encoding type I IFNs in the brain's choroid …

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …

Objective The objective is to summarize the knowledge on the epidemiology,
pathophysiology and management of secondary headache attributed to SARS-CoV-2 …

Long COVID and especially headache syndromes : Current Opinion in Neurology Long COVID
and especially headache syndromes : Current Opinion in Neurology Log in or Register …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continually evolving
resulting in variants with increased transmissibility, more severe disease, reduced …

Background and purpose Core clinical manifestations of COVID‐19 include influenza‐like
and respiratory symptoms. However, it is now evident that neurological involvement may …

Angiotensin Converting Enzyme 2 (ACE-2), Transmembrane Serine Protease 2 (TMPRSS-
2) and Neuropilin-1 cellular receptors support the entry of SARS-CoV-2 into susceptible …

Background: There is an urgent need to better understand the mechanisms underlying acute
and long-term neurological symptoms after COVID-19. Neuropathological studies can …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an array of
neurologic and neuropsychiatric symptoms in the acute and post-acute phase of infection …